Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GLREGREENLIGHT CAPITAL RE, LTD.

Nasdaq · CIK 0001385613
Filer categoryAccelerated filer
Entity typeoperating
SIC6331 Fire, Marine & Casualty Insurance
FY end1231
XBRL facts486

Identity from submissions API

NameGREENLIGHT CAPITAL RE, LTD.
CIK0001385613
TickersGLRE
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC6331 Fire, Marine & Casualty Insurance
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone345 943 4573
Website—
Investor website—
Owner org02 Finance
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
65 MARKET STREET, SUITE 1207,
CAMANA BAY, P.O. BOX 31110
GRAND CAYMAN
KY1-1205
Cayman Islands
E9
Mailing address
65 MARKET STREET, SUITE 1207,
CAMANA BAY, P.O. BOX 31110
GRAND CAYMAN
KY1-1205
Cayman Islands
E9

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

962 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001142031-26-000029 005-82906 261535235 34 7288
2026-11-06 4 FORM 4 0001385613-26-000142 5604
2026-11-05 144 xsl144X01/primary_doc.xml 0001949846-26-000635 001-33493 261526047 33 5596
2026-11-02 4 xslF345X06/form4.xml 0000929638-26-004186 7146
2026-11-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000929638-26-004184 005-82906 261513073 34 10605
2026-11-02 10-Q 10-Q 0001385613-26-000140 001-33493 261512797 34 9907430 1 1
2026-11-02 8-K 8-K 1.01,2.02,5.02 0001385613-26-000138 001-33493 261512553 34 3860598 1 1
2026-09-29 4 FORM 4 0001385613-26-000133 8799
2026-09-18 4 FORM 4 0001385613-26-000131 5003
2026-09-16 4 FORM 4 0001385613-26-000129 6900
2026-09-04 4 FORM 4 0001385613-26-000127 5287
2026-09-04 3 FORM 3 0001385613-26-000125 4123
2026-09-01 8-K 8-K 5.02,8.01,9.01 0001385613-26-000123 001-33493 261350978 34 173334 1 1
2026-08-31 4 FORM 4 0001385613-26-000121 8928
2026-08-25 144 xsl144X01/primary_doc.xml 0001949846-26-000543 001-33493 261315745 33 8868
2026-08-11 4 FORM 4 0001385613-26-000119 9460
2026-08-10 4 FORM 4 0001385613-26-000116 5118
2026-08-07 4 FORM 4 0001385613-26-000114 5138
2026-08-07 4 FORM 4 0001385613-26-000111 5184
2026-08-07 4 FORM 4 0001385613-26-000109 5300
2026-08-07 4 FORM 4 0001399967-26-000002 5300
2026-08-07 4 FORM 4 0001385613-26-000105 6696
2026-08-07 4 FORM 4 0001385613-26-000103 5239
2026-08-07 4 FORM 4 0001385613-26-000100 7169
2026-08-05 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000929638-26-002882 005-82906 261241439 34 10613
2026-08-04 4 xslF345X06/form4.xml 0000929638-26-002877 7145
2026-08-04 10-Q 10-Q 0001385613-26-000098 001-33493 261239595 34 10255412 1 1
2026-08-04 8-K 8-K 1.01,2.02,9.01 0001385613-26-000097 001-33493 261239565 34 3505183 1 1
2026-08-03 8-K 8-K 5.07,9.01 0001385613-26-000093 001-33493 261232765 34 174995 1 1
2026-07-31 3 FORM 3 0001385613-26-000090 4020
2026-07-01 4 FORM 4 0001385613-26-000086 6372
2026-06-26 4 FORM 4 0001385613-26-000084 7742
2026-06-25 4 FORM 4 0001385613-26-000082 6043
2026-06-24 4 FORM 4 0001385613-26-000080 8807
2026-06-02 144 xsl144X01/primary_doc.xml 0001949846-26-000336 001-33493 261053966 33 4573
2026-06-01 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000929638-26-002101 005-82906 261051709 34 9847
2026-06-01 8-K 8-K 1.01 0001385613-26-000078 001-33493 261051248 34 295799 1 1
2026-05-27 4 FORM 4 0001385613-26-000076 6379
2026-05-20 4 FORM 4 0001385613-26-000074 6840
2026-05-18 4 FORM 4 0001385613-26-000072 6601
2026-05-15 4 FORM 4 0001385613-26-000070 5804
2026-05-14 144/A xsl144X01/primary_doc.xml 0001628280-26-034953 001-33493 26977554 33 5003
2026-05-14 144 xsl144X01/primary_doc.xml 0001628280-26-034942 001-33493 26977432 33 4910
2026-05-14 4 FORM 4 0001385613-26-000068 8128
2026-05-11 144 xsl144X01/primary_doc.xml 0001965301-26-000052 001-33493 26962527 33 5149
2026-05-08 4 FORM 4 0001385613-26-000066 5343
2026-05-05 8-K 8-K 2.02,9.01 0001385613-26-000064 001-33493 26943646 34 3185620 1 1
2026-05-05 10-Q 10-Q 0001385613-26-000062 001-33493 26943592 34 8778634 1 1
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001664 005-82906 26901051 34 11193
2026-04-24 DEF 14A DEF 14A 0001385613-26-000057 001-33493 26893720 34 16708957 1 1
2026-04-07 4/A FORM 4/A 0001385613-26-000054 5718
2026-04-07 4/A FORM 4/A 0001385613-26-000052 5671
2026-04-07 4/A FORM 4/A 0001385613-26-000050 5708
2026-04-07 4/A FORM 4/A 0001385613-26-000048 5692
2026-04-07 4/A FORM 4/A 0001385613-26-000046 5650
2026-04-06 8-K 8-K 1.01,2.03,5.02,9.01 0001385613-26-000044 001-33493 26841364 34 153283 1 1
2026-03-16 4 FORM 4 0001385613-26-000041 5097
2026-03-16 4 FORM 4 0001385613-26-000039 5337
2026-03-16 4 FORM 4 0001385613-26-000037 5154
2026-03-16 4 FORM 4 0001385613-26-000035 5118
2026-03-16 4 FORM 4 0001385613-26-000033 5139
2026-03-16 4 FORM 4 0001385613-26-000031 5165
2026-03-16 4 FORM 4 0001385613-26-000029 5155
2026-03-16 4 FORM 4 0001385613-26-000027 5117
2026-03-11 4 FORM 4 0001385613-26-000025 4931
2026-03-11 4 FORM 4 0001385613-26-000022 4975
2026-03-11 4 FORM 4 0001385613-26-000019 4990
2026-03-11 4 FORM 4 0001385613-26-000016 4990
2026-03-11 4 FORM 4 0001385613-26-000014 5001
2026-03-11 4 FORM 4 0001385613-26-000012 5176
2026-03-09 10-K 10-K 0001385613-26-000010 001-33493 26735689 34 32145414 1 1
2026-03-09 8-K 8-K 2.02,9.01 0001385613-26-000009 001-33493 26735391 34 3299748 1 1
2026-02-05 8-K 8-K 5.02 0001385613-26-000003 001-33493 26603072 34 141705 1 1
2025-11-21 4 FORM 4 0001385613-25-000121 5206
2025-11-19 4 FORM 4 0001385613-25-000119 6931
2025-11-10 4 FORM 4 0001385613-25-000117 7261
2025-11-07 4 FORM 4 0001385613-25-000115 4848
2025-11-03 10-Q 10-Q 0001385613-25-000113 001-33493 251444481 34 11041593 1 1
2025-11-03 8-K 8-K 2.02,9.01 0001385613-25-000112 001-33493 251444391 34 3392110 1 1
2025-09-19 4 FORM 4 0001385613-25-000105 6694
2025-09-17 144 xsl144X01/primary_doc.xml 0001949846-25-000487 001-33493 251319510 33 5818
2025-09-15 144 xsl144X01/primary_doc.xml 0001949846-25-000476 001-33493 251314151 33 5815
2025-09-15 144 xsl144X01/primary_doc.xml 0001949846-25-000475 001-33493 251314029 33 5822
2025-09-09 8-K 8-K 1.01,2.03,9.01 0001385613-25-000103 001-33493 251303738 34 155624 1 1
2025-08-12 4 FORM 4 0001385613-25-000098 4851
2025-08-08 4 FORM 4 0001385613-25-000096 5051
2025-08-08 4 FORM 4 0001385613-25-000094 6447
2025-08-08 4 FORM 4 0001385613-25-000092 4944
2025-08-08 4 FORM 4 0001385613-25-000090 4990
2025-08-08 4 FORM 4 0001385613-25-000088 6920
2025-08-08 4 FORM 4 0001385613-25-000085 4964
2025-08-08 4 FORM 4 0001385613-25-000083 5905
2025-08-05 8-K 8-K 2.02,5.07,9.01 0001385613-25-000081 001-33493 251181810 34 3373047 1 1
2025-08-04 10-Q 10-Q 0001385613-25-000079 001-33493 251181390 34 8732982 1 1
2025-06-26 4 FORM 4 0001385613-25-000076 6701
2025-06-24 144 xsl144X01/primary_doc.xml 0001949846-25-000303 001-33493 251068255 33 5684
2025-06-18 4 FORM 4 0001385613-25-000074 6697
2025-06-16 144 xsl144X01/primary_doc.xml 0001949846-25-000291 001-33493 251050205 33 4488
2025-05-14 4 FORM 4 0001385613-25-000067 7876
2025-05-13 DEFA14A DEFA14A 0001385613-25-000064 001-33493 25937945 34 455948
2025-05-07 8-K 8-K 2.02,9.01 0001385613-25-000062 001-33493 25922768 34 401130 1 1
2025-05-07 10-Q 10-Q 0001385613-25-000058 001-33493 25922422 34 8281246 1 1
2025-04-17 DEF 14A DEF 14A 0001385613-25-000055 001-33493 25844176 34 36969856 1 1
2025-03-27 4 FORM 4 0001385613-25-000046 4967
2025-03-17 4 FORM 4 0001385613-25-000044 5023
2025-03-17 4 FORM 4 0001385613-25-000042 4989
2025-03-17 4 FORM 4 0001385613-25-000040 4997
2025-03-17 4 FORM 4 0001385613-25-000038 4954
2025-03-17 4 FORM 4 0001385613-25-000036 4975
2025-03-17 4 FORM 4 0001385613-25-000034 5013
2025-03-17 4 FORM 4 0001385613-25-000032 5083
2025-03-17 4 FORM 4 0001385613-25-000030 5012
2025-03-17 4 FORM 4 0001385613-25-000028 4973
2025-03-11 4 FORM 4 0001385613-25-000026 5059
2025-03-11 4 FORM 4 0001385613-25-000024 4853
2025-03-11 4 FORM 4 0001385613-25-000022 4884
2025-03-11 4 FORM 4 0001385613-25-000020 4859
2025-03-11 4 FORM 4 0001385613-25-000018 4875
2025-03-11 4 FORM 4 0001385613-25-000016 4815
2025-03-11 3 FORM 3 0001385613-25-000013 4695
2025-03-10 8-K 8-K 2.02,9.01 0001385613-25-000011 001-33493 25724659 34 529197 1 1
2025-03-10 10-K 10-K 0001385613-25-000007 001-33493 25724379 34 32718141 1 1
2024-12-20 8-K 8-K 1.01,2.03,9.01 0001385613-24-000125 001-33493 241568339 34 159970 1 1
2024-11-19 8-K 8-K 9.01 0001385613-24-000118 001-33493 241473437 34 5368143 1 1
2024-11-04 10-Q 10-Q 0001385613-24-000113 001-33493 241424309 34 8569876 1 1
2024-11-04 8-K 8-K 9.01 0001385613-24-000111 001-33493 241423943 34 431653 1 1
2024-09-30 4 FORM 4 0001385613-24-000107 8468
2024-09-26 144 xsl144X01/primary_doc.xml 0001949846-24-000590 001-33493 241327754 33 4393
2024-08-12 4 FORM 4 0001385613-24-000105 4971
2024-08-12 4 FORM 4 0001385613-24-000103 6367
2024-08-12 4 FORM 4 0001385613-24-000101 4864
2024-08-12 4 FORM 4 0001385613-24-000099 5825
2024-08-12 4 FORM 4 0001385613-24-000097 4884
2024-08-12 4 FORM 4 0001385613-24-000095 4910
2024-08-12 4 FORM 4 0001385613-24-000093 6840
2024-08-06 8-K 8-K 1.01,9.01 0001385613-24-000091 001-33493 241179795 34 171844 1 1
2024-08-06 10-Q 10-Q 0001385613-24-000089 001-33493 241179742 34 8410987 1 1
2024-08-06 8-K 8-K 9.01 0001385613-24-000088 001-33493 241179706 34 428323 1 1
2024-07-29 8-K 8-K 9.01 0001385613-24-000084 001-33493 241152790 34 182500 1 1
2024-07-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-05 14:00:00 9999999995-24-002082 333-280421 241103261 33 1884
2024-07-02 CORRESP filename1.htm 0001385613-24-000079 9409
2024-07-01 S-3/A S-3/A 0001385613-24-000077 333-280421 241088416 33 351150
2024-06-28 S-3/A S-3/A 0001385613-24-000074 333-280421 241085815 33 348690
2024-06-26 UPLOAD filename1.pdf 0000000000-24-007241 333-280421 40435
2024-06-21 S-3 S-3 0001385613-24-000070 333-280421 241061458 33 622449
2024-05-30 8-K 8-K 1.01,9.01 0001385613-24-000059 001-33493 241005734 34 169667 1 1
2024-05-14 DEFA14A DEFA14A 0001385613-24-000057 001-33493 24941646 34 989761
2024-05-08 10-Q 10-Q 0001385613-24-000053 001-33493 24926622 34 7543514 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001385613-24-000051 001-33493 24926554 34 366426 1 1
2024-04-25 DEF 14A DEF 14A 0001385613-24-000044 001-33493 24877555 34 12061973 1 1
2024-04-19 4/A FORM 4/A 0001385613-24-000040 6443
2024-04-18 8-K 8-K 1.02 0001385613-24-000037 001-33493 24852835 34 149398 1 1
2024-03-28 4 FORM 4 0001385613-24-000034 6718
2024-03-19 4 FORM 4 0001385613-24-000032 5193
2024-03-19 4 FORM 4 0001385613-24-000030 5124
2024-03-19 4 FORM 4 0001385613-24-000028 5159
2024-03-19 4 FORM 4 0001385613-24-000026 5188
2024-03-19 4 FORM 4 0001385613-24-000024 5170
2024-03-19 4 FORM 4 0001385613-24-000022 5167
2024-03-19 4/A FORM 4/A 0001385613-24-000020 5506
2024-03-19 4 FORM 4 0001385613-24-000018 5205
2024-03-05 10-K 10-K 0001385613-24-000016 001-33493 24722149 34 29625503 1 1
2024-03-05 8-K 8-K 2.02,9.01 0001385613-24-000014 001-33493 24721032 34 419656 1 1
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0000354204-24-002898 005-82906 24612158 34 19638
2024-02-02 SC 13G/A kyg4095j1094_020224.txt 0001086364-24-006233 005-82906 24590266 34 13563
2024-01-08 4 FORM 4 0001385613-24-000006 5605
2024-01-08 3 FORM 3 0001385613-24-000004 20729
2023-12-27 8-K 8-K 1.01,2.03,9.01 0001385613-23-000119 001-33493 231518360 34 161348 1 1
2023-12-11 SC 13G/A MS AMENDMENT 0000895421-23-000517 005-82906 231478429 34 12913
2023-11-08 8-K 8-K 2.02,5.02 0001385613-23-000115 001-33493 231388870 34 750348 1 1
2023-11-08 10-Q 10-Q 0001385613-23-000112 001-33493 231388219 34 8037169 1 1
2023-08-07 4 FORM 4 0001385613-23-000108 5749
2023-08-07 4 FORM 4 0001385613-23-000106 4895
2023-08-07 4 FORM 4 0001385613-23-000104 6291
2023-08-07 4 FORM 4 0001385613-23-000102 4808
2023-08-07 4 FORM 4 0001385613-23-000100 6764
2023-08-07 4 FORM 4 0001385613-23-000098 4835
2023-08-07 4 FORM 4 0001385613-23-000096 4789
2023-08-02 8-K 8-K 2.02,9.01 0001385613-23-000094 001-33493 231137153 34 426727 1 1
2023-08-02 10-Q 10-Q 0001385613-23-000092 001-33493 231136940 34 7968684 1 1
2023-07-31 S-8 S-8 0001385613-23-000088 333-273538 231127608 33 315201
2023-07-27 8-K 8-K 5.07,9.01 0001385613-23-000082 001-33493 231118807 34 890492 1 1
2023-07-27 4 xslF345X05/form4.xml 0000929638-23-002120 11104
2023-07-27 SC 13D/A AMENDMENT NO. 1 0000929638-23-002119 005-82906 231118348 34 53294
2023-07-03 4 FORM 4 0001385613-23-000078 6525
2023-06-30 4 FORM 4 0001385613-23-000076 5990
2023-06-28 144 xsl144X01/primary_doc.xml 0001949846-23-000172 001-33493 231052884 33 4308
2023-06-22 8-K 8-K 1.01,9.01 0001385613-23-000074 001-33493 231033762 34 1572109 1 1
2023-05-16 4 FORM 4 0001385613-23-000069 4851
2023-05-11 DEFA14A DEFA14A 0001385613-23-000066 001-33493 23910083 34 656133
2023-05-09 8-K 8-K 2.02,9.01 0001385613-23-000062 001-33493 23903090 34 394014 1 1
2023-05-09 10-Q 10-Q 0001385613-23-000060 001-33493 23903043 34 7213715 1 1
2023-05-02 3 FORM 3 0001385613-23-000048 9426
2023-04-26 DEF 14A DEF 14A 0001385613-23-000045 001-33493 23849727 34 51014048 1 1
2023-03-31 PRE 14A PRE 14A 0001385613-23-000041 001-33493 23782781 34 50335467 1 1
2023-03-17 4 FORM 4 0001385613-23-000035 5179
2023-03-17 4 FORM 4 0001385613-23-000034 5140
2023-03-17 4 FORM 4 0001385613-23-000033 5170
2023-03-17 4 FORM 4 0001385613-23-000032 5265
2023-03-17 4 FORM 4 0001385613-23-000031 5112
2023-03-17 4 FORM 4 0001385613-23-000030 5160
2023-03-17 4 FORM 4 0001385613-23-000029 5156
2023-03-09 8-K 8-K 5.02,9.01 0001385613-23-000021 001-33493 23720572 34 565573 1 1
2023-03-09 3 FORM 3 0001385613-23-000019 9367
2023-03-09 3 FORM 3 0001385613-23-000018 9347
2023-03-08 10-K 10-K 0001385613-23-000012 001-33493 23716615 34 29901574 1 1
2023-03-08 8-K 8-K 2.02,9.01 0001385613-23-000010 001-33493 23716424 34 455197 1 1
2023-02-13 SC 13G SC 13G 0001104659-23-019076 005-82906 23614884 34 53154
2023-02-10 SC 13G/A SEC SCHEDULE 13G 0000354204-23-001318 005-82906 23610661 34 19562
2023-02-09 SC 13G/A MS AMENDMENT 0000895421-23-000112 005-82906 23605170 34 17829
2023-02-01 SC 13G/A kyg4095j1094_013123.txt 0001306550-23-005866 005-82906 23573884 34 13315
2022-12-21 8-K 8-K 1.01,9.01 0001385613-22-000134 001-33493 221476090 34 196425 1 1
2022-11-17 8-K 8-K 7.01,9.01 0001385613-22-000130 001-33493 221396942 34 5179854 1 1
2022-11-02 8-K 8-K 2.02,9.01 0001385613-22-000123 001-33493 221354827 34 444754 1 1
2022-11-02 10-Q 10-Q 0001385613-22-000120 001-33493 221354569 34 9398138 1 1
2022-10-25 8-K 8-K 5.02,9.01 0001385613-22-000111 001-33493 221329154 34 373640 1 1
2022-10-17 8-K 8-K 8.01,9.01 0001385613-22-000109 001-33493 221314126 34 197225 1 1
2022-10-05 8-K 8-K 5.02,9.01 0001385613-22-000105 001-33493 221296229 34 189071 1 1
2022-08-05 4 FORM 4 0001385613-22-000102 6250
2022-08-05 4 FORM 4 0001385613-22-000101 4734
2022-08-05 4 FORM 4 0001385613-22-000100 5700
2022-08-05 4 FORM 4 0001385613-22-000099 4838
2022-08-05 4 FORM 4 0001385613-22-000098 6683
2022-08-05 4 FORM 4 0001385613-22-000097 4780
2022-08-05 4 FORM 4 0001385613-22-000096 4751
2022-08-02 8-K 8-K 2.02,9.01 0001385613-22-000087 001-33493 221129344 34 444083 1 1
2022-08-02 10-Q 10-Q 0001385613-22-000085 001-33493 221129085 34 9064316 1 1
2022-07-29 8-K 8-K 5.07 0001385613-22-000078 001-33493 221122016 34 307020 1 1
2022-05-17 DEFA14A DEFA14A 0001385613-22-000075 001-33493 22932946 34 1513948
2022-05-03 8-K 8-K 2.02,9.01 0001385613-22-000070 001-33493 22888288 34 388741 1 1
2022-05-03 10-Q 10-Q 0001385613-22-000068 001-33493 22888191 34 8171383 1 1
2022-04-28 DEF 14A DEF 14A 0001385613-22-000057 001-33493 22867246 34 2760510
2022-03-17 4 FORM 4 0001385613-22-000050 5140
2022-03-17 4 FORM 4 0001385613-22-000049 5226
2022-03-17 4 FORM 4 0001385613-22-000048 5144
2022-03-17 4 FORM 4 0001385613-22-000047 5112
2022-03-17 4 FORM 4 0001385613-22-000046 5160
2022-03-17 4 FORM 4 0001385613-22-000045 5156
2022-03-17 4 FORM 4 0001385613-22-000044 5154
2022-03-08 8-K 8-K 2.02,9.01 0001385613-22-000028 001-33493 22722677 34 419565 1 1
2022-03-08 10-K 10-K 0001385613-22-000026 001-33493 22722571 34 28732372 1 1
2022-02-28 8-K 8-K 5.02,9.01 0001385613-22-000018 001-33493 22684364 34 338442 1 1
2022-02-25 8-K 8-K 8.01,9.01 0001385613-22-000012 001-33493 22673184 34 195012 1 1
2022-02-18 SC 13G GREENLIGHT CAPITAL RE, LTD. 0001104659-22-025086 005-82906 22652101 34 47494
2022-02-10 SC 13G/A MS AMENDMENT 0000895421-22-000213 005-82906 22613975 34 17650
2022-02-08 SC 13G/A SEC SCHEDULE 13G 0000354204-22-001472 005-82906 22601045 34 19562
2022-02-03 SC 13G/A kyg4095j1094_020222.txt 0000834237-22-005426 005-82906 22585685 34 13329
2022-01-31 8-K 8-K 8.01,9.01 0001385613-22-000009 001-33493 22571557 34 190266 1 1
2022-01-26 8-K 8-K 7.01 0001385613-22-000005 001-33493 22556143 34 177302 1 1
2021-12-16 UPLOAD filename1.pdf 0000000000-21-015035 39683
2021-12-16 CORRESP filename1.htm 0001385613-21-000128 44384
2021-12-08 UPLOAD filename1.pdf 0000000000-21-014746 43126
2021-11-12 CORRESP filename1.htm 0001385613-21-000125 49254
2021-11-03 8-K 8-K 2.02,9.01 0001385613-21-000122 001-33493 211376245 34 420407 1 1
2021-11-03 10-Q 10-Q 0001385613-21-000120 001-33493 211376109 34 8595611 1 1
2021-10-21 CORRESP filename1.htm 0001385613-21-000114 16585
2021-10-18 UPLOAD filename1.pdf 0000000000-21-012580 44862
2021-10-06 8-K 8-K 4.01,9.01 0001385613-21-000112 001-33493 211308182 34 180909 1 1
2021-08-10 4 FORM 4 0001385613-21-000109 4749
2021-08-10 4 FORM 4 0001385613-21-000108 4732
2021-08-10 4 FORM 4 0001385613-21-000107 4778
2021-08-09 3 FORM 3 0001385613-21-000103 9393
2021-08-09 3 FORM 3 0001385613-21-000102 9367
2021-08-09 3 FORM 3 0001385613-21-000101 9413
2021-08-03 8-K 8-K 2.02,5.02,8.01,9.01 0001385613-21-000094 001-33493 211140288 34 557762 1 1
2021-08-03 10-Q 10-Q 0001385613-21-000092 001-33493 211140208 34 8491279 1 1
2021-07-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-07-16 16:00:00 9999999995-21-002814 333-257613 211096723 33 1841
2021-07-12 CORRESP filename1.htm 0001385613-21-000084 7344
2021-07-08 UPLOAD filename1.pdf 0000000000-21-008397 40318
2021-07-01 S-3 S-3 0001385613-21-000082 333-257613 211066524 33 1029959
2021-06-30 8-K 8-K 1.01,9.01 0001385613-21-000074 001-33493 211062354 34 189262 1 1
2021-05-12 4 FORM 4 0001385613-21-000070 11599
2021-05-11 4 FORM 4 0001385613-21-000068 10334
2021-05-11 4 FORM 4 0001385613-21-000067 11739
2021-05-11 4 FORM 4 0001385613-21-000066 12191
2021-05-11 4 FORM 4 0001385613-21-000065 10323
2021-05-05 8-K 8-K 2.02,5.07,9.01 0001385613-21-000053 001-33493 21894402 34 467679 1 1
2021-05-05 10-Q 10-Q 0001385613-21-000051 001-33493 21893988 34 7318243 1 1
2021-04-20 DEFA14A DEFA14A 0001385613-21-000044 001-33493 21838695 34 49126
2021-03-19 DEFA14A DEFA14A 0001385613-21-000040 001-33493 21756809 34 1601671
2021-03-16 4 FORM 4 0001385613-21-000036 4849
2021-03-16 4 FORM 4 0001385613-21-000035 5051
2021-03-16 4 FORM 4 0001385613-21-000034 4871
2021-03-16 4 FORM 4 0001385613-21-000033 4823
2021-03-16 4 FORM 4 0001385613-21-000032 4869
2021-03-16 4 FORM 4 0001385613-21-000031 4864
2021-03-16 4 FORM 4 0001385613-21-000030 4865
2021-03-12 DEF 14A DEF 14A PROXY STATEMENT 0001385613-21-000022 001-33493 21735599 34 1218979
2021-03-10 8-K 8-K 2.02,9.01 0001385613-21-000018 001-33493 21730293 34 439260 1 1
2021-03-10 10-K 10-K 0001385613-21-000016 001-33493 21730228 34 29722752 1 1
2021-02-12 SC 13G/A SEC SCHEDULE 13G 0000354204-21-000075 005-82906 21625944 34 19571
2021-02-12 SC 13G/A GLRE13g123120.txt 0001036325-21-000015 005-82906 21623330 34 9834
2021-02-11 SC 13G/A MS AMENDMENT 0000895421-21-000170 005-82906 21619329 34 17554
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018210 005-82906 21610894 34 14049
2021-01-29 SC 13G/A kyg4095j1094_012921.txt 0000834237-21-003716 005-82906 21568597 34 13302
2021-01-12 8-K 8-K 1.01,8.01,9.01 0001385613-21-000005 001-33493 21523786 34 874039 1 1
2020-11-12 4 FORM 4 0001385613-20-000100 5700
2020-11-12 4 FORM 4 0001385613-20-000099 4838
2020-11-12 4 FORM 4 0001385613-20-000098 6250
2020-11-12 4 FORM 4 0001385613-20-000097 6637
2020-11-12 4 FORM 4 0001385613-20-000096 4825
2020-11-04 IRANNOTICE IRANNOTICE 0001385613-20-000090 001-33493 201287370 34 41167
2020-11-04 S-8 S-8 0001385613-20-000087 333-249849 201287037 33 255189
2020-11-04 8-K 8-K 2.02,5.02,5.07,9.01 0001385613-20-000085 001-33493 201286904 34 535298 1 1
2020-11-04 10-Q 10-Q 0001385613-20-000083 001-33493 201286830 34 8462215 1 1
2020-09-15 4 FORM 4 0001385613-20-000074 4845
2020-09-15 DEFA14A DEFA14A 2019 YE 0001385613-20-000072 001-33493 201175114 34 1525627
2020-09-09 4 FORM 4 0001385613-20-000070 4940
2020-09-09 8-K 8-K 5.02,8.01,9.01 0001385613-20-000067 001-33493 201167248 34 626199 1 1
2020-09-09 DEF 14A DEF 14A 0001385613-20-000065 001-33493 201166739 34 2512654
2020-08-05 IRANNOTICE IRANNOTICE 0001385613-20-000062 001-33493 201078390 34 42604
2020-08-05 8-K FORM 8-K Q2 2020 2.02,5.02,9.01 0001385613-20-000061 001-33493 201078322 34 699416 1 1
2020-08-05 10-Q 10-Q 0001385613-20-000060 001-33493 201078293 34 10233929 1 1
2020-08-03 4 FORM 4 0001385613-20-000052 5457
2020-07-21 8-K 8-K 7.01,9.01 0001385613-20-000050 001-33493 201037812 34 109365
2020-06-05 4 FORM 4 0001385613-20-000047 5180
2020-05-05 IRANNOTICE IRANNOTICE 0001385613-20-000045 001-33493 20849468 34 43739
2020-05-05 8-K 8-K 2.02,5.02,9.01 0001385613-20-000043 001-33493 20849352 34 274031
2020-05-05 10-Q 10-Q 0001385613-20-000041 001-33493 20849203 34 6523029 1
2020-04-29 10-K/A 10-K/A 0001385613-20-000037 001-33493 20831386 34 1154722
2020-04-13 8-K 8-K 2.02,8.01,9.01 0001385613-20-000034 001-33493 20787945 34 105119
2020-04-06 8-K 8-K PRESS RELEASE APR 2020 8.01,9.01 0001385613-20-000032 001-33493 20775108 34 70996
2020-03-18 4 FORM 4 0001385613-20-000030 4859
2020-03-18 4 FORM 4 0001385613-20-000029 5050
2020-03-18 4 FORM 4 0001385613-20-000028 4872
2020-03-18 4 FORM 4 0001385613-20-000027 4845
2020-03-18 4 FORM 4 0001385613-20-000026 4869
2020-03-18 4 FORM 4 0001385613-20-000025 4834
2020-03-18 4 FORM 4 0001385613-20-000024 4949
2020-03-18 4 FORM 4 0001385613-20-000023 4864
2020-03-10 IRANNOTICE IRANNOTICE Q4 2019 0001385613-20-000014 001-33493 20699081 34 43742
2020-03-09 10-K 10-K GLRE 2019 0001385613-20-000012 001-33493 20699029 34 31821643 1
2020-03-09 8-K 8-K 2.02,9.01 0001385613-20-000009 001-33493 20698386 34 288221
2020-02-13 SC 13G/A GLRE13g123119.txt 0001036325-20-000020 005-82906 20608715 34 9610
2020-02-12 SC 13G/A MS AMENDMENT 0000895421-20-000116 005-82906 20604485 34 17513
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001258897-20-001043 005-82906 20601796 34 53115
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-20-018710 005-82906 20601744 34 13845
2020-02-05 SC 13G/A kyg4095j1094_020420.txt 0000834237-20-005352 005-82906 20577355 34 13521
2019-12-30 8-K 8-K LETTER AGREEMENT DEC 2019 1.01,9.01 0001385613-19-000108 001-33493 191317000 34 44551
2019-11-06 IRANNOTICE IRANNOTICE 0001385613-19-000106 001-33493 191197024 34 43747
2019-11-06 8-K 8-K Q3 2019 EARNINGS RELEASE 2.02,9.01 0001385613-19-000103 001-33493 191196917 34 336737
2019-11-06 10-Q 10-Q 0001385613-19-000101 001-33493 191196869 34 8399658 1
2019-09-23 8-K 8-K TRANSACTION BONUS 5.02,9.01 0001385613-19-000096 001-33493 191108730 34 156007
2019-09-03 8-K 8-K SEPT 2 2019 5.02,9.01 0001385613-19-000093 001-33493 191072808 34 72217
2019-08-12 8-K 8-K BOARD ITEM AUG 9 2019 5.02 0001385613-19-000090 001-33493 191017074 34 22271
2019-08-05 IRANNOTICE IRANNOTICE 0001385613-19-000085 001-33493 19999290 34 43711
2019-08-05 8-K 8-K 2.02,9.01 0001385613-19-000084 001-33493 19999255 34 336049
2019-08-05 10-Q FORM 10-Q Q2 2019 0001385613-19-000082 001-33493 19999099 34 8196649 1
2019-06-13 SC 13G/A efc19-430_sc13ga.htm 0000905148-19-000638 005-82906 19896546 34 133894
2019-06-13 SC 13G/A efc19-429_sc13ga.htm 0000905148-19-000637 005-82906 19896521 34 133359
2019-06-13 SC 13G efc19-428_sc13g.htm 0000905148-19-000636 005-82906 19896467 34 132498
2019-05-31 8-K 8-K - REG FD 7.01 0001385613-19-000076 001-33493 19871060 34 26287
2019-05-13 4 FORM 4 0001385613-19-000073 4625
2019-05-13 4 FORM 4 0001385613-19-000072 5699
2019-05-13 4 FORM 4 0001385613-19-000071 4836
2019-05-13 4 FORM 4 0001385613-19-000070 4809
2019-05-13 4 FORM 4 0001385613-19-000069 6249
2019-05-13 4 FORM 4 0001385613-19-000068 6636
2019-05-13 4 FORM 4 0001385613-19-000067 4824
2019-05-06 IRANNOTICE IRANNOTICE 0001385613-19-000059 001-33493 19800406 34 43705
2019-05-06 8-K 8-K Q1 2019 EARNINGS RELEASE 2.02,5.07,9.01 0001385613-19-000057 001-33493 19800144 34 440631
2019-05-06 10-Q 10-Q Q1 2019 0001385613-19-000053 001-33493 19799732 34 7160622 1
2019-05-03 S-8 S-8 0001385613-19-000049 333-231214 19796908 33 158200
2019-05-03 UPLOAD filename1.pdf 0000000000-19-008043 39614
2019-03-19 4 FORM 4 0001385613-19-000044 4859
2019-03-19 4 FORM 4 0001385613-19-000043 5320
2019-03-19 4 FORM 4 0001385613-19-000042 4823
2019-03-19 4 FORM 4 0001385613-19-000041 4869
2019-03-19 4 FORM 4 0001385613-19-000040 4834
2019-03-19 4 FORM 4 0001385613-19-000039 4949
2019-03-19 4 FORM 4 0001385613-19-000038 4864
2019-03-19 DEFA14A DEFA14A AGM NOTICE 0001385613-19-000029 001-33493 19690781 34 1530675
2019-03-15 10-K/A 10-K/A 0001385613-19-000027 001-33493 19685645 34 4902949
2019-03-12 DEF 14A DEF 14A 2018 0001385613-19-000022 001-33493 19675831 34 2273634
2019-02-27 IRANNOTICE IRANNOTICE 0001385613-19-000019 001-33493 19638671 34 43517
2019-02-27 8-K 8-K 2.02,9.01 0001385613-19-000017 001-33493 19638630 34 312124
2019-02-27 10-K 10-K 2018 0001385613-19-000016 001-33493 19638474 34 26259578 1
2019-02-14 SC 13G 13G GREENLIGHT DECEMBER 2018 0000764532-19-000003 005-82906 19602582 34 7855
2019-02-13 SC 13G DAVIS SELECTED ADVISERS 0001036325-19-000018 005-82906 19596585 34 9539
2019-02-12 SC 13G/A MS AMENDMENT 0000895421-19-000064 005-82906 19588712 34 17184
2019-02-11 SC 13G/A greenlightcapitalreltd.htm 0000932471-19-005079 005-82906 19584035 34 34299
2019-02-08 SC 13G/A SCHEDULE 13G/A 0001258897-19-000915 005-82906 19577315 34 53145
2019-02-04 SC 13G/A kyg4095j1094_020419.txt 0000215457-19-004094 005-82906 19564428 34 13533
2019-01-23 8-K 8-K JAN 22 2019 7.01 0001385613-19-000008 001-33493 19536617 34 24307
2019-01-14 CORRESP filename1.htm 0001385613-19-000006 43892
2019-01-04 3 FORM 3 0001385613-19-000004 8808
2019-01-02 8-K 8-K COMPLETION OF JV DISPOSITION 2.01 0001385613-19-000002 001-33493 19502670 34 22846
2018-12-21 UPLOAD filename1.pdf 0000000000-18-039086 49677
2018-12-07 8-K 8-K ITEM 5.02 CAO 5.02,9.01 0001385613-18-000149 001-33493 181223875 34 167345
2018-11-15 8-K 8-K INVESTOR DAY 2018 7.01,9.01 0001385613-18-000146 001-33493 181187565 34 3101862
2018-11-05 8-K 8-K Q3 2018 EARNINGS RELEASE 2.02,9.01 0001385613-18-000144 001-33493 181160436 34 389244
2018-11-05 IRANNOTICE IRANNOTICE Q3 2018 0001385613-18-000142 001-33493 181160215 34 43317
2018-11-05 10-Q 10-Q Q3 2018 0001385613-18-000141 001-33493 181160064 34 13601174 1
2018-11-02 3 FORM 3 0001385613-18-000136 8571
2018-09-13 8-K 8-K - REG FD 7.01 0001385613-18-000133 001-33493 181067556 34 23063
2018-09-04 4 FORM 4 0001385613-18-000130 4996
2018-09-04 8-K 8-K - INVESTMENT AGREEMENTS 1.01,1.02,9.01 0001385613-18-000128 001-33493 181051407 34 710601
2018-08-07 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001193125-18-241143 001-33493 18998312 34 688042
2018-08-02 8-K 8-K 7.01,8.01,9.01 0001193125-18-235710 001-33493 18986764 34 31675
2018-07-31 IRANNOTICE IRANNOTICE Q2 2018 0001385613-18-000126 001-33493 18982002 34 43311

Latest XBRL company facts

One latest value per concept from companyfacts (486 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 32.24M 2026-10-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
dei EntityPublicFloat Entity Public Float USD 376.00M 2025-06-30 2025 FY 10-K 2026-03-09 0001385613-26-000010
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt pure 0.138 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.31M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.30M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 234.32 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.83M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.31M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 199.45 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001385613-26-000057
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 25.00M 2025-05-02 2026 Q1 10-Q 2026-05-05 0001385613-26-000062
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 2.80M 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 300,000 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.48M 2016-12-31 2016 FY 10-K 2017-02-22 0001385613-17-000007
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 456.24M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 7.90M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 83,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-20 0001385613-18-000013
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.67M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-05 0001385613-20-000060
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.70M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 500,000 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap AllowanceForNotesAndLoansReceivableNoncurrent Financing Receivable, Allowance for Credit Loss, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap AlternativeInvestment Alternative Investment USD 235.61M 2018-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap AlternativeInvestmentsFairValueDisclosure Alternative Investment, Fair Value Disclosure (Deprecated 2018-01-31) USD 235.61M 2018-12-31 2019 Q1 10-Q 2019-05-06 0001385613-19-000053
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -8.20M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 13.30M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 927,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001385613-18-000141
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap AssetManagementCosts Asset Management Costs (Deprecated 2018-01-31) USD 35.66M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap Assets Assets USD 2.29B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 37.57M 2018-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap AssumedPremiumsWritten Assumed Premiums Written USD 592.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap BenefitsLossesAndExpenses Benefits, Losses and Expenses USD 465.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CapitalRequiredForCapitalAdequacy Banking Regulation, Total Risk-Based Capital, Capital Adequacy, Minimum USD 50.00M 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 70.98M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -106.24M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 582.97M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -60.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 1.07B 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries USD 15.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap CededPremiumsEarned Ceded Premiums Earned USD 92.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CededPremiumsWritten Ceded Premiums Written USD 119.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 2.64M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.1 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 125.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 32.46M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 32.46M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap CommonStockValue Common Stock, Value, Issued USD 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 1 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap ContractualObligation Contractual Obligation USD 111.43M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 0 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 0 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 657,000 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 4.59M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 104.62M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 640,000 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 130,000 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 4.72M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -886,000 2020-01-01 2020 Q1 10-Q 2020-05-05 0001385613-20-000041
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 671,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap DebtAndEquitySecuritiesRealizedGainLoss Debt and Equity Securities, Realized Gain (Loss) USD -800,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-04 0001385613-24-000113
us-gaap DebtAndEquitySecuritiesUnrealizedGainLoss Debt and Equity Securities, Unrealized Gain (Loss) USD 388,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 58.44M 2025-06-30 2025 Q2 10-Q 2025-08-04 0001385613-25-000079
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD -6.36M 2012-09-30 2012 Q3 10-Q 2012-10-31 0001385613-12-000042
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 1.60M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 8.20M 2018-08-07 2020 Q2 10-Q 2020-08-05 0001385613-20-000060
us-gaap DebtSecuritiesTradingGainLoss Debt Securities, Trading, Gain (Loss) USD -2.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DebtSecuritiesTradingRealizedGain Debt Securities, Trading, Realized Gain USD 658,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap DebtSecuritiesTradingRealizedGainLoss Debt Securities, Trading, Realized Gain (Loss) USD -132,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DebtSecuritiesTradingRealizedLoss Debt Securities, Trading, Realized Loss USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap DebtSecuritiesTradingRestricted Debt Securities, Trading, Restricted USD 97.88M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DebtSecuritiesTradingUnrealizedGainLoss Debt Securities, Trading, Unrealized Gain (Loss) USD -2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DebtSecuritiesTradingUnrealizedLoss Debt Securities, Trading, Unrealized Loss USD 1.10M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001385613-24-000113
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 900,000 2023-06-16 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 4,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DeferredPolicyAcquisitionCostAmortizationExpense Deferred Policy Acquisition Costs, Amortization Expense USD 136.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DeferredPolicyAcquisitionCosts Deferred Policy Acquisition Cost USD 98.51M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 1.09M 2023-12-31 2023 FY 10-K 2024-03-05 0001385613-24-000016
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 374,000 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 0 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 1.97M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap DepositAssetsAmortizatonExpenseFromExpirations Deposit Assets, Amortizaton Expense from Expirations USD 500,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap DepositAssetsOrLiabilitiesAmortizationExpenseFromExpirations Deposit Assets or Liabilities, Amortization Expense from Expirations (Deprecated 2013-01-31) USD 500,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap DepositContractsAssets Deposit Contracts, Assets USD 0 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap DepositContractsLiabilities Deposit Contracts, Liabilities USD 3.60M 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap Depreciation Depreciation USD 44,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001385613-24-000016
us-gaap DerivativeAssetFairValueGrossLiability Derivative Asset, Fair Value, Gross Liability USD 0 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeAssetFairValueNet Derivative Asset, Fair Value, Net (Deprecated 2013-01-31) USD 56.12M 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap DerivativeAssets Derivative Asset USD 0 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeCollateralObligationToReturnCash Derivative, Collateral, Obligation to Return Cash USD 1.34M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeCollateralObligationToReturnSecurities Derivative, Collateral, Obligation to Return Securities USD 5.13M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeCollateralRightToReclaimCash Derivative, Collateral, Right to Reclaim Cash USD 17.09M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeCollateralRightToReclaimSecurities Derivative, Collateral, Right to Reclaim Securities USD 5.13M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeFairValueOfDerivativeAsset Derivative Asset, Fair Value, Gross Asset USD 12.89M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral Derivative Asset, Fair Value, Amount Not Offset Against Collateral USD 85.56M 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral Derivative Asset, Fair Value, Amount Offset Against Collateral USD 6.43M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 22.22M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral Derivative Liability, Fair Value, Amount Not Offset Against Collateral USD 17.96M 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral Derivative Liability, Fair Value, Amount Offset Against Collateral USD 0 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 86.78M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap DerivativeInstrumentsGainLossRecognizedInIncomeNet Derivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31) USD 59.26M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD -39.55M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeLiabilities Derivative Liability USD 100,000 2024-03-31 2024 Q1 10-Q 2024-05-08 0001385613-24-000053
us-gaap DerivativeLiabilityFairValueGrossAsset Derivative Liability, Fair Value, Gross Asset USD 0 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap DerivativeLiabilityFairValueNet1 Derivative Liability, Fair Value, Net (Deprecated 2013-01-31) USD -27.34M 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 3.96M 2017-09-30 2017 Q3 10-Q 2017-10-30 0001385613-17-000090
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.044 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap EffectOfExchangeRateOnCash Effect of Exchange Rate on Cash USD -3.37M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-03 0001385613-22-000068
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 3.40M 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 300,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap EntityWideRevenueMajorCustomerAmount Entity-Wide Revenue, Major Customer, Amount (Deprecated 2013-01-31) USD 354.21M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap EntityWideRevenueMajorCustomerPercentage Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) pure 0.827 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap EquityMethodInvestmentsFairValueDisclosure Equity Method Investments, Fair Value Disclosure USD 258.90M 2023-12-31 2023 FY 10-K 2024-03-05 0001385613-24-000016
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap EquitySecuritiesFvNiCost Equity Securities, FV-NI, Cost USD 30.55M 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap EquitySecuritiesFvNiCurrentAndNoncurrent EquitySecuritiesFvNiCurrentAndNoncurrent USD 63.18M 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap EquitySecuritiesFvNiRealizedGain Equity Securities, FV-NI, Realized Gain USD 4.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD 3.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EquitySecuritiesFvNiRealizedLoss Equity Securities, FV-NI, Realized Loss USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EquitySecuritiesFvNiUnrealizedGain Equity Securities, FV-NI, Unrealized Gain USD 38.26M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 5.71M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 5.74M 2018-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount USD 0 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-04 0001385613-26-000098
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount USD 32.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount USD 17.86M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount USD 3.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount USD 62.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ExperienceRatedRefundsPayable Experience Rated Refunds Payable (Deprecated 2013-01-31) USD 10.00M 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings USD -1.03M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2018-09-30 2018 Q3 10-Q 2018-11-05 0001385613-18-000141
us-gaap FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) USD -1.50M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome Fair Value, Assets Measured on Recurring Basis, Change in Unrealized Gain (Loss) Included in Investment Income (Deprecated 2013-01-31) USD -1.50M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap FairValueAssetsMeasuredOnRecurringBasisGainLossIncludedInInvestmentIncome Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Investment Income (Deprecated 2013-01-31) USD -300,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap FairValueAssetsMeasuredOnRecurringBasisGainLossIncludedInOtherIncome Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) USD 0 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Redemption Restriction, Percentage pure 1 2018-09-30 2018 Q3 10-Q 2018-11-05 0001385613-18-000141
us-gaap FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments USD 9.90M 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-07-31 0001385613-18-000124
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases USD 800,000 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-05 0001385613-19-000082
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales USD 664,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-07-31 0001385613-18-000124
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-05 0001385613-19-000082
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 51.06M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap FinancialInstrumentsOwnedCorporateEquitiesAtFairValue Financial Instruments, Owned, Corporate Equities, at Fair Value USD 1.03B 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap FinancialInstrumentsSoldNotYetPurchasedAtFairValue Financial Instruments Sold, Not yet Purchased, at Fair Value USD 0 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap FinancialInstrumentsSoldNotYetPurchasedCorporateDebt Financial Instruments Sold, Not yet Purchased, Corporate Debt USD 203.82M 2014-06-30 2014 Q2 10-Q 2014-08-04 0001385613-14-000106
us-gaap FinancialInstrumentsSoldNotYetPurchasedCorporateEquities Financial Instruments Sold, Not yet Purchased, Corporate Equities USD 812.65M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap FinancialInstrumentsSoldNotYetPurchasedOtherSovereignGovernmentDebt Financial Instruments Sold, Not yet Purchased, Other Sovereign Government Debt USD 100.14M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease Financing Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 6.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap FinancingReceivableRecordedInvestmentNonaccrualStatus Financing Receivable, Nonaccrual USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -5.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 7.60M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 218,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-31 0001385613-12-000042
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 3.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap FundsHeldUnderReinsuranceAgreementsLiability Funds Held under Reinsurance Agreements, Liability USD 43.73M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 3.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap GainLossOnRepurchaseOfDebtInstrument Gain (Loss) on Repurchase of Debt Instrument USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap GainLossOnSaleOfNotesReceivable Gain (Loss) on Sale of Financing Receivable USD 4.50M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-17 0001385613-15-000012
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 31.56M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001385613-24-000113
us-gaap ImpairedFinancingReceivableInterestIncomeCashBasisMethod Impaired Financing Receivable, Interest Income, Cash Basis Method USD 0 2014-01-01 2014-03-31 2015 Q1 10-Q 2015-05-04 0001385613-15-000046
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-22 0001385613-17-000007
us-gaap IncentiveFeeExpense Incentive Fee Expense USD 4.71M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001385613-24-000113
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD 69.33M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 57.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 78.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 20.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -79.21M 2018-10-01 2018-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -9.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncomeLossIncludingPortionAttributableToNoncontrollingInterest Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax USD 10.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncomeTaxesPaid Income Taxes Paid USD 4,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 662,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 123,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap IncreaseDecreaseInDeferredPolicyAcquisitionCosts Increase (Decrease) in Deferred Policy Acquisition Costs USD -1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001385613-18-000141
us-gaap IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements Increase (Decrease) in Funds Held under Reinsurance Agreements USD -27.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve USD 56.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve Increase (Decrease) in Loss and Loss Adjustment Expense Reserve (Deprecated 2015-01-31) USD -41.75M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 546,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 4.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -1.95M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap IncreaseDecreaseInPayablesToBrokerDealers Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap IncreaseDecreaseInPremiumsReceivable Increase (Decrease) in Premiums Receivable USD 18.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInPrepaidReinsurancePremiums Increase (Decrease) in Prepaid Reinsurance Premiums USD 27.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInReinsurancePayables Increase (Decrease) in Reinsurance Payables USD 13.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInReinsuranceRecoverable Increase (Decrease) in Reinsurance Recoverable USD 36.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 308.24M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-20 0001385613-18-000013
us-gaap IncreaseDecreaseInUnearnedPremiums Increase (Decrease) in Unearned Premiums USD 39.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncreaseDecreaseInUnearnedPremiumsNet (Increase) Decrease in Unearned Premiums, Net USD -3.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 607,980 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap IncurredClaimsPropertyCasualtyAndLiability Policyholder Benefits and Claims Incurred, Net, Property, Casualty and Liability USD 238.99M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap InsuranceCommissions Insurance Commissions USD -1.30M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap InsuranceRecoveries Insurance Recoveries USD 3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 2.33M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap InterestAndDividendIncomeSecuritiesTradingOrMeasuredAtFairValue Interest and Dividend Income, Securities, Operating, Trading or Measured at Fair Value USD 35.47M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap InterestExpense Interest Expense USD 4.68M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001385613-21-000120
us-gaap InterestExpenseDeposits Interest Expense, Deposits USD 109,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InterestExpenseOther Interest Expense, Other USD 354,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InterestIncomeDepositsWithFinancialInstitutions Interest Income, Deposits with Financial Institutions USD 2.10M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -645,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap InterestIncomeOther Interest Income, Other USD 2.75M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001385613-19-000082
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 11.09M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 308,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InterestReceivable Interest Receivable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 0 2015-12-31 2016 Q1 10-Q 2016-05-02 0001385613-16-000147
us-gaap InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency USD -185,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 10.87M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap InvestmentInPhysicalCommoditiesFairValueDisclosure Investment in Physical Commodities, Fair Value Disclosure USD 121.50M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap Investments Investments USD 731.74M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 487.38M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap InvestmentSoldNotYetPurchasedAtFairValue Investment Sold, Not yet Purchased, at Fair Value USD 912.80M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 600,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.16M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 698,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 559,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 654,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 635,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 617,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 149,000 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 485,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 268.20M 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap Liabilities Liabilities USD 1.60B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.29B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 912.80M 2017-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap LiabilityForClaimsAndClaimsAdjustmentExpense Liability for Claims and Claims Adjustment Expense USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability Liability for Claims and Claims Adjustment Expense, Property Casualty Liability USD 730.65M 2024-03-31 2024 Q1 10-Q 2024-05-08 0001385613-24-000053
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid (Deprecated 2014-01-31) USD 347.89M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year (Deprecated 2014-01-31) USD 177.87M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year USD 17.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years (Deprecated 2014-01-31) USD 170.02M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years USD 245.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTranslationGainLoss Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Currency Translation Gain (Loss) USD -4.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignExchange Liability for Unpaid Claims and Claims Adjustment Expense, Foreign Exchange (Deprecated 2016-01-31) USD -2.33M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseGross Liability for Unpaid Claims and Claims Adjustment Expense, Gross (Deprecated 2014-01-31) USD 329.89M 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount USD 747.19M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims (Deprecated 2014-01-31) USD 338.49M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims USD 287.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Current Year (Deprecated 2014-01-31) USD 344.61M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims, Prior Years (Deprecated 2014-01-31) USD -6.12M 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet Liability for Unpaid Claims and Claims Adjustment Expense, Net USD 906.53M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments USD 13.60M 2022-06-30 2022 Q2 10-Q 2022-08-02 0001385613-22-000085
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) USD -4.80M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-04 0001385613-20-000083
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedAndIncurredButNotReportedIBNRClaims Liability for Unpaid Claims and Claims Adjustment Expense, Reported and Incurred but Not Reported (IBNR) Claims (Deprecated 2014-01-31) USD 329.89M 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount USD 277.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LineOfCredit Long-term Line of Credit USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 575.00M 2025-03-31 2025 Q1 10-Q 2025-05-07 0001385613-25-000058
us-gaap LongTermDebt Long-term Debt USD 4.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap LossFromCatastrophes Loss from Catastrophes USD 29.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ManagementFeeExpense Management Fee Expense USD 9.81M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 2.18M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap MinorityInterestInJointVentures Noncontrolling Interest in Joint Ventures USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap MinorityInterestInNetIncomeLossJointVenturePartners Net Income (Loss) Attributable to Noncontrolling Interest, Joint Venture Partners (Deprecated 2013-01-31) USD 3.52M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap MinorityInterestPeriodIncreaseDecrease Noncontrolling Interest, Period Increase (Decrease) USD -485,000 2019-01-01 2019-06-30 2020 Q2 10-Q 2020-08-05 0001385613-20-000060
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -27.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -107.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 73.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 9.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 9.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 9.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NetInvestmentIncome Net Investment Income USD 21.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 2.08M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap NonredeemableNoncontrollingInterest Nonredeemable Noncontrolling Interest USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 0 2021-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 2 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ObligationToReturnSecuritiesReceivedAsCollateral Obligation to Return Securities Received as Collateral USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap OperatingLeaseCost Operating Lease, Cost USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-04 0001385613-20-000083
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.68M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.70M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 401,000 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 169,000 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 63,000 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 169,000 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 135,000 2015-09-30 2015 Q3 10-Q 2015-10-23 0001385613-15-000101
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 0 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-06 0001385613-19-000101
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.06 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 1.60M 2014-12-31 2014 FY 10-K 2015-02-17 0001385613-15-000012
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 0 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap OtherAssets Other Assets USD 8.79M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap OtherExpenses Other Expenses USD 16.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap OtherInvestmentNotReadilyMarketableFairValue Other Investment Not Readily Marketable, Fair Value USD 5.74M 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap OtherInvestments Other Investments USD 65.45M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap OtherLiabilities Other Liabilities USD 11.78M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap OtherPayablesToBrokerDealersAndClearingOrganizations Other Payables to Broker-Dealers and Clearing Organizations USD 13.69M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001385613-18-000141
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 24.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PayablesToBrokerDealersAndClearingOrganizations Payables to Broker-Dealers and Clearing Organizations USD 0 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap PaymentsForDerivativeInstrumentInvestingActivities Payments for Derivative Instrument, Investing Activities USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap PaymentsForLossesAndLossAdjustmentExpense Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid USD 263.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001385613-24-000016
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 27.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PaymentsForRepurchaseOfOtherEquity Payments for Repurchase of Other Equity USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-21 0001385613-12-000009
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 54.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.04B 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-31 0001385613-12-000042
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 3.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 111,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap PaymentsToAcquireTradingSecuritiesHeldforinvestment Payments to Acquire Trading Securities Held-for-investment USD 140.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments Pledged Assets, Not Separately Reported, Other USD 97.40M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001385613-16-000214
us-gaap PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForLetterOfCreditFacilities Pledged Financial Instruments, Not Separately Reported, Securities for Letter of Credit Facilities USD 185.50M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001385613-22-000068
us-gaap PolicyholderBenefitsAndClaimsIncurredNet Policyholder Benefits and Claims Incurred, Net USD 287.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.1 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PremiumsAndOtherReceivablesNet Premiums and Other Receivables, Net USD 683.36M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PremiumsEarnedNet Premiums Earned, Net USD 469.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PremiumsReceivableAtCarryingValue Premiums Receivable, Net USD 683.36M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PremiumsReceivableGross Premiums Receivable, Gross USD 684.71M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PremiumsWrittenNet Premiums Written, Net USD 472.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PrepaidReinsurancePremiums Prepaid Reinsurance Premiums USD 66.85M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD -2.60M 2014-01-01 2014-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap ProceedsFromDerivativeInstrumentInvestingActivities Proceeds from Derivative Instrument, Investing Activities USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap ProceedsFromDivestitureOfInterestInJointVenture Proceeds from Divestiture of Interest in Joint Venture USD 2.08M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital Proceeds from Equity Method Investment, Distribution, Return of Capital USD 62.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD -169,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ProceedsFromInterestReceived Proceeds from Interest Received USD 2.73M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-10-30 0001385613-17-000090
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 17,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-29 0001385613-13-000056
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 513,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 4.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 19.10M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001385613-21-000016
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-20 0001385613-18-000013
us-gaap ProceedsFromPaymentsForTradingSecurities Proceeds from (Payments for) Trading Securities, Short-term USD 5,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-04 0001385613-25-000079
us-gaap ProceedsFromPaymentsToMinorityShareholders Proceeds from (Payments to) Noncontrolling Interests USD -1.28M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001385613-19-000101
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 6.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 4.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 1.39B 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-10-31 0001385613-12-000042
us-gaap ProceedsFromSaleOfTradingSecuritiesHeldforinvestment Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment USD 20.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 75,000 2002-08-01 2002-08-31 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 86.83M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001385613-24-000016
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.18M 2016-12-31 2016 FY 10-K 2017-02-22 0001385613-17-000007
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 698,000 2016-12-31 2016 FY 10-K 2017-02-22 0001385613-17-000007
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 225,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001385613-24-000113
us-gaap ProvisionForLoanLeaseAndOtherLosses Provision for Loan, Lease, and Other Losses USD 15.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments Realized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments USD -87.60M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-20 0001385613-18-000013
us-gaap ReinsuranceCostsAndRecoveriesNet Policyholder Benefits and Claims Incurred, Assumed and Ceded USD 57.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ReinsurancePayable Reinsurance Payable USD 109.70M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountAssumedFromOtherCompanies Reinsurance Premiums for Insurance Companies, by Product Segment, Amount Assumed from Other Companies (Deprecated 2013-01-31) USD 427.84M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ReinsurancePremiumsForInsuranceCompaniesByProductSegmentAmountCededToOtherCompanies Reinsurance Premiums for Insurance Companies, by Product Segment, Amount Ceded to Other Companies (Deprecated 2013-01-31) USD -24.27M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ReinsurancePremiumsForInsuranceCompaniesByProductSegmentGrossAmount Reinsurance Premiums for Insurance Companies, by Product Segment, Gross Amount (Deprecated 2013-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmount Reinsurance Premiums for Insurance Companies, by Product Segment, Net Amount (Deprecated 2013-01-31) USD 452.12M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ReinsurancePremiumsForInsuranceCompaniesByProductSegmentPercentageOfAmountAssumedToNet Reinsurance Premiums for Insurance Companies, by Product Segment, Percentage of Amount Assumed to Net (Deprecated 2013-01-31) pure 0.95 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments Reinsurance Recoverable for Unpaid Claims and Claims Adjustments USD 118.36M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ReinsuranceRecoverables Reinsurance Recoverables, Including Reinsurance Premium Paid USD 81.39M 2025-12-31 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap ReinsuranceRecoverablesAllowance Reinsurance Recoverable, Allowance for Credit Loss USD 1.35M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap RepaymentsOfDebt Repayments of Debt USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap RepaymentsOfSeniorDebt Repayments of Senior Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 511.98M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 235.06M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 54.84M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap Revenues Revenues USD 475.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 19 2007-05-30 2013 Q3 10-Q 2013-10-30 0001385613-13-000071
us-gaap SecuritiesOwnedNotReadilyMarketable Securities Owned Not Readily Marketable (Deprecated 2019-01-31) USD 4.00M 2018-06-30 2018 Q2 10-Q 2018-07-31 0001385613-18-000124
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral Securities Sold under Agreements to Repurchase, Amount Offset Against Collateral USD 0 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseAsset Securities Sold under Agreements to Repurchase, Asset USD 0 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Cash USD 1.11B 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap SecuritiesSoldUnderAgreementsToRepurchaseGross Securities Sold under Agreements to Repurchase, Gross USD 1.11B 2013-12-31 2013 FY 10-K 2014-02-18 0001385613-14-000017
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 1 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001385613-18-000141
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 7,492 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 25.36 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 148,471 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 24.6 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 308,406 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 24.93 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 191,136 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 3.30M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 17.34 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.314 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.023 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 3.50M 2012-09-30 2012 Q3 10-Q 2012-10-31 0001385613-12-000042
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.14M 2012-09-30 2012 Q3 10-Q 2012-10-31 0001385613-12-000042
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 200,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 629,636 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 20.32 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 45,290 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 10.25 2020-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 700,000 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 835,627 2020-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 22.22 2020-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 50,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 4.31 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 23.8 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net USD 879.96M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item USD 535,000 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense Short-duration Insurance Contracts, Liability for Unpaid Claims and Claims Adjustment Expense, Accumulated Unallocated Claim Adjustment Expense USD 6.08M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 300,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001385613-22-000026
us-gaap StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends Statutory Accounting Practices, Retained Earnings Not Available for Dividends USD 325.29M 2015-12-31 2015 FY 10-K 2016-02-22 0001385613-16-000118
us-gaap StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance Statutory Accounting Practices, Statutory Capital and Surplus, Balance USD 759.60M 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired Statutory Accounting Practices, Statutory Capital and Surplus Required USD 310.60M 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap StatutoryAccountingPracticesStatutoryNetIncomeAmount Statutory Accounting Practices, Statutory Net Income Amount USD 15.30M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 694.55M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 694.55M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 65,394 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 142,828 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 56,934 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 56,322 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001385613-25-000113
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001385613-22-000120
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 44,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-05 0001385613-20-000060
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001385613-23-000112
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 20.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 25.00M 2023-05-02 2023 FY 10-K 2024-03-05 0001385613-24-000016
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 2.00M 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 1.77M 2011-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Amount USD 128.52M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Cost USD 30.82M 2024-12-31 2024 FY 10-K 2025-03-10 0001385613-25-000007
us-gaap SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Fair Value USD 128.52M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense Current Year Claims and Claims Adjustment Expense USD 286.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense Prior Year Claims and Claims Adjustment Expense USD 717,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Amortization of Deferred Policy Acquisition Cost USD 184.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses USD 411.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Deferred Policy Acquisition Cost USD 99.95M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Liability for Future Policy Benefit, Loss, Claim and Loss Expense USD 967.96M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationNetInvestmentIncome SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Net Investment Income USD 24.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationOtherOperatingExpense SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Other Operating Expense USD 28.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationPremiumRevenue SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Revenue USD 661.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationPremiumsWritten SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Premium Written USD 691.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap SupplementaryInsuranceInformationUnearnedPremiums SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Unearned Premium USD 361.70M 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 442,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0001385613-23-000012
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap TradingSecuritiesCost Trading Securities, Cost USD 50.52M 2018-12-31 2019 Q1 10-Q 2019-05-06 0001385613-19-000053
us-gaap TradingSecuritiesDebt Debt Securities, Trading USD 178.91M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap TradingSecuritiesEquity Trading Securities, Equity USD 36.91M 2018-12-31 2019 Q1 10-Q 2019-05-06 0001385613-19-000053
us-gaap TradingSecuritiesRealizedGain Trading Securities, Realized Gain USD 303.67M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap TradingSecuritiesRealizedLoss Trading Securities, Realized Loss USD 540.56M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001385613-19-000016
us-gaap TradingSecuritiesUnrealizedHoldingGain Trading Securities, Unrealized Holding Gain USD 1.01M 2018-01-01 2018-12-31 2019 Q1 10-Q 2019-05-06 0001385613-19-000053
us-gaap TradingSecuritiesUnrealizedHoldingGainLoss Trading Securities, Change in Unrealized Holding Gain (Loss) USD 67.60M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap TradingSecuritiesUnrealizedHoldingLoss Trading Securities, Unrealized Holding Loss USD 14.63M 2018-01-01 2018-12-31 2019 Q1 10-Q 2019-05-06 0001385613-19-000053
us-gaap TransferOfInvestments Transfer from Investments USD 36.70M 2019-01-01 2019-03-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap UnderwritingIncomeLoss Underwriting Income (Loss) USD 20.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap UnearnedPremiums Unearned Premiums USD 401.15M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 1.50M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001385613-24-000113
us-gaap UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments Unrealized Gain (Loss) on Marketable Securities, Cost Method Investments, and Other Investments USD 67.57M 2012-01-01 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap UnusedCommitmentsToExtendCredit Unused Commitments to Extend Credit USD 400,000 2019-12-31 2019 FY 10-K 2020-03-09 0001385613-20-000012
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD 0 2012-12-31 2012 FY 10-K 2013-02-19 0001385613-13-000005
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001385613-26-000010
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001385613-22-000068
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 33.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 33.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001385613-26-000140

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →